Vicore Pharma Holding
9.81 SEK
-2.68 %
Less than 1K followers
VICO
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vicore Pharma Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1 | 109.4 | 0.9 | 1.8 | 0.8 | 0.4 | 3.8 | |
| EBITDA | -60.1 | -83.9 | -184.0 | -91.6 | -111.2 | -116.0 | -133.7 | -452.4 |
| EBIT | -60.1 | -94.1 | -194.2 | -91.6 | -111.2 | -116.0 | -133.7 | -452.4 |
| EBIT-% | -1,841.1 % | -177.6 % | -10,286.5 % | -6,352.6 % | -15,258.3 % | -31,911.0 % | -11,851.9 % | |
| Profit before taxes | -60.0 | -84.1 | -168.9 | -111.5 | -115.4 | -113.5 | -137.1 | -477.5 |
| Net income | -60.0 | -84.1 | -168.6 | -111.5 | -115.4 | -113.5 | -137.1 | -477.5 |